CEL-SCI Corporation today highlights strong biological rationale for the use of Multikine in the confirmatory registration head and neck cancer study. This study of 212 newly diagnosed locally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback